Amorepacific invests in HIGHER Corporation
Analysis based on 9 articles · First reported Jul 27, 2026 · Last updated Jul 31, 2026
The strategic investment and partnership are expected to strengthen Amorepacific Corporation's position in the growing medical aesthetics market, potentially boosting its growth prospects. HIGHER Corporation gains access to Amorepacific Corporation's resources and distribution, which could accelerate its international expansion and product development.
Amorepacific Corporation Holdings, Korea's leading beauty company, announced on July 27, 2026 that it signed a strategic investment agreement with HIGHER Corporation, a medical aesthetics company specializing in injectable solutions and aesthetic medical devices. The agreement includes a strategic investment by Amorepacific Corporation in HIGHER Corporation. The collaboration will focus on developing and commercializing medical aesthetics products such as skin boosters, cosmeceuticals, and medical devices; developing and distributing post-treatment aftercare products through clinics and hospitals; and conducting joint research on ingredients and materials, supported by marketing initiatives. The companies aim to combine Amorepacific Corporation's skin science and brand assets with HIGHER Corporation's global network of medical professionals and market expertise to create integrated solutions bridging professional treatments and daily skincare. HIGHER Corporation's flagship brand, HILO WAVE®, a Dual-HA collagen booster platform, is expected to benefit from the partnership. The agreement was announced via press releases on July 30-31, 2026.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard